Today: July 14, 2024
January 19, 2024
1 min read

Dutch Startups Secure Record Funding in Q4 2023, Scaling Challenges Persist


  • Dutch startups raised €576M in Q4 2023, a decrease of 5% compared to the previous year.
  • The number of deals in Q4 increased by 36% compared to Q3 2023.

In Q4 2023, Dutch startups raised €576 million in investments, a decrease of 5% compared to the previous year. However, the number of deals increased by 36% compared to Q3 2023. Biotech companies dominated the top 10 deals of the quarter, with VectorY Therapeutics securing €129 million. Fintech companies also saw increased investment. 2023 marked a 27% decrease in funding for Dutch startups and scale-ups compared to the previous year, but this decline is less noticeable than the global average. Several large venture capital funds emerged in the life sciences sector over the past year, including Forbion Ventures Fund VI and Gilde Healthcare Venture & Growth VI. There are still funds with available capital to invest, and with expectations for steady growth in startup investments, 2024 looks promising for Dutch startups.

Previous Story

CerraCap Ventures Fuels Acorai, Propelling Revolutionary Heart Failure Management

Next Story

Closing the Gender Financing Gap: GreenTech Leads the Way

Latest from Blog

Go toTop